AzTrials
AzTrials

Cardiac Bypass Surgery (CABG)CASESNCT06360224

Collect Flow and Ultrasound Images of Coronary Bypass Grafts

An observational study of Cardiac Bypass Surgery (CABG), run by Medistim ASA.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

This is a post-market observational, non-interventional, multicenter clinical investigation with the purpose of harvesting high quality data from regular cardiac bypass surgery (CABG). Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Cardiac Bypass Surgery (CABG)
What is being tested?
MiraQ systems with Transit Time Flow Measurement (TTFM) and High Frequency Ultrasound (HFUS) probes
Type of treatment
Medical device
How many people
100 participants
Where
No sites listed yet
Study dates
15 May 2024to 15 May 2029
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Patients scheduled for cardiac bypass surgery (CABG) that have signed an informed consent form for this study

Who may be able to join

  • Patient older than 18 years
  • Scheduled for CABG
  • Understand the nature of the procedure and willingness to comply with the CIP
  • Provide written informed consent

Who cannot join

  • Patient younger than 18 years
  • Any condition that the investigator believes should exclude participation

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

About this study

This is a post-market observational, non-interventional, multicenter clinical investigation with the purpose of harvesting high quality data from regular cardiac bypass surgery (CABG).

Being tested
MiraQ systems with Transit Time Flow Measurement (TTFM) and High Frequency Ultrasound (HFUS) probes

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • MiraQ systems with Transit Time Flow Measurement (TTFM) and High Frequency Ultrasound (HFUS) probesDevice

    The objective of this study is to harvest a wide dataset of high quality to allow exploratory analysis and training of machine learning

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Wide and high-quality dataset uploaded to CaseCloud from CABG-procedures.

    Measured: 1 day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Apr 2024
  2. Study start15 May 2024 (estimated)
  3. Primary completion15 May 2029 (estimated)
  4. Study completion15 May 2029 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Prospective
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06360224
Sponsor's protocol ID
CASES
Acronym
CASES
Status last verified
Apr 2024
First submitted
6 Apr 2024
Last updated
11 Apr 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Cardiac Bypass Surgery (CABG), run by Medistim ASA.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 11 Apr 2024. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Haakon Grøthe (04790968263, haakon.groethe@medistim.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Wide and high-quality dataset uploaded to CaseCloud from CABG-procedures. (time frame: 1 day). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Apr 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in